Skip to content

Prognostic analysis of patients with FIGO stage IB3-IIA2 cervical cancer undergoing radical hysterectomy: A cross-sectional study

Prognostic analysis of patients with FIGO stage IB3-IIA2 cervical cancer undergoing radical hysterectomy: A cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092075
Enrollment
Unknown
Registered
2024-11-08
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Observation group:None

Sponsors

Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) All selected patients were diagnosed with cervical squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma through histological biopsy or cytological examination; (2) Patients must be aged = 18 years and = 75 years; (3) Imaging (chest X-ray, cardiac ultrasound) and electrocardiogram data show no significant abnormalities; (4) Laboratory examination: serum bilirubin and creatinine levels must not exceed 1.5 times the upper limit of normal; Hemoglobin concentration must be = 90g/L; White blood cell count must be = 4 * 109/L and = 10 * 109/L; Platelet count must be = 100 * 109/L; Absolute neutrophil count must be = 2 * 109/L; (5) All patients have signed informed consent forms for chemotherapy and surgery.

Exclusion criteria

Exclusion criteria: (1) Individuals with other systemic malignancies, such as gastrointestinal malignancies, breast malignancies, etc.; (2) Individuals with severe heart, liver, lung, and kidney dysfunction; (3) Individuals who are allergic to chemotherapy drugs, have severe mental disorders, and experience gastrointestinal bleeding; (4) Patients with cervical cancer who relapsed after receiving treatment (5) Patients with severe malnutrition (BMI < 16 kg/m²) prior to admission.

Design outcomes

Primary

MeasureTime frame
Overall survival;

Secondary

MeasureTime frame
Progression-free survival;

Countries

China

Contacts

Public ContactMingfu Wu

Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology

mingfuwutj@163.com+86 137 2017 2196

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026